1. GlaxoSmithKline Pharma
stock logo

50% Buy

GlaxoSmithKline Pharma Share Price

GLAXO

₹2,725.00+₹12.75 (0.47%) TodayLast updated on 01 Nov, 2024 | 18:59 IST

GlaxoSmithKline Pharma Share Price Chart

Please wait...
  • About GlaxoSmithKline Pharma
  • Fundamentals
  • Events
  • More
  • News

About GlaxoSmithKline Pharma

GlaxoSmithKline Pharma Financials

arrow
Market cap
Market Cap Switch₹45,947 Crs
Open
₹2,729.00
Close
₹2,712.25
Circuit range
₹3,279.70 - ₹2,186.50
Day range
₹2,721.10 - ₹2,742.95
Year range
₹1,408.15 - ₹3,088.00
Volume
6,923
Avg. traded
₹2,734.77
Revenue (12m)
₹3,560 Crs
GlaxoSmithKline PharmaGlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company has three product areas: vaccines, specialty and general medicine. Its general medicines business has a portfolio of medicines in anti-infectives, pain, vitamins medicine, nutritional, hormones, dermatologicals, respiratory and vaccines for adults and children. The Company's general medicine brands include Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, Tenovate, T-bact and Physiogel. The Company's vaccine brands include Shingrix Herpes Zoster Vaccine, Infanrix Hexa, Synflorix, Boostrix, Havrix, Menveo, Fluarix Tetra and Varilrix. Its specialty medicine brands include Nucala, Seretide, and Trelegy Ellipta. Trelegy Ellipta, single inhaler triple therapy (SITT) for chronic obstructive pulmonary disease (COPD) patients. The Subsidiary of the Company is Biddle Sawyer Limited.

Glaxosmithkline Pharma Key indicators

arrow
52 week high
₹3,088.00
52 week low
₹1,408.15
P/E ratio
68.49
P/B ratio
22.63
ROE
32.96%
ROCE
45.85%
Dividend yield
1.21%
Debt/Equity ratio
EPS
34.51

Learn more

Investment checklist: (3/6)
arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

50%

Hold

50%

Sell

0%

This analysis is based on the reviews of 4 experts in the last 7 days

GlaxoSmithKline Pharma Fundamentals

GlaxoSmithKline Pharma Financial Ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

27.4%

Net profit margin

15.64%

ROE

32.96%

ROA

17.73%

ROCE

45.85%

Learn more

GlaxoSmithKline Pharma Shareholder returns

arrow
1 day
+0.77%
1 week
+5.58%
1 month
-0.08%
3 months
-0.91%
1 year
+94.27%
3 years
+71.08%
5 years
+63.49%

Glaxosmithkline Pharma Share Price history

arrow
DayOpenCloseChange %
Fri, Nov 1 2024
₹2,729.00
₹2,733.10
+0.77%
Thu, Oct 31 2024
₹2,670.00
₹2,712.25
+1.42%
Wed, Oct 30 2024
₹2,676.00
₹2,674.25
+1.70%
Tue, Oct 29 2024
₹2,642.00
₹2,629.65
-0.57%
Mon, Oct 28 2024
₹2,588.60
₹2,644.65
+2.17%
Fri, Oct 25 2024
₹2,638.10
₹2,588.60
-1.12%
Thu, Oct 24 2024
₹2,635.35
₹2,618.05
-0.47%
Wed, Oct 23 2024
₹2,578.05
₹2,630.50
+2.01%

GlaxoSmithKline Pharma Shareholding Pattern

arrow

Promoters (75%)

Mutual Funds (4.98%)

Retail and other (13.3%)

Foreign institutions-FII (4.36%)

Other domestic institutions (2.35%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹32/share

    Ex date 31 May 2024

    expand tab
  • Dividend • ₹32/share

    Ex date 30 Jun 2023

    expand tab
  • Dividend • ₹60/share

    Ex date 07 Jul 2022

    expand tab
  • Dividend • ₹30/share

    Ex date 07 Jul 2022

    expand tab

Learn more

FAQs on GlaxoSmithKline Pharma